Profound Medical (TSE:PRN) has released an update.
Profound Medical Corp., a company known for its incision-free ablation therapies, will reveal its first quarter financial results for 2024 on May 9, followed by a conference call to discuss the outcomes. The call will be accessible live via the company’s website. Profound Medical is recognized for its TULSA-PRO and Sonalleve technologies, which offer non-invasive treatment options for various medical conditions.
For further insights into TSE:PRN stock, check out TipRanks’ Stock Analysis page.
